StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.44−0.15 (-3.30%)

Close on Nov 18, 2026Market cap $61.80MP/E –Yield –

Champions Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Champions Oncology's price to book ratio was 17.1× on Nov 11, 2026, against 25.7× a year earlier. Over the last 5 years it ranged from 6.1× to 221.1×, with a median of 18.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.1×−5.9
2025Dec 31, 202523.0×−149.4
2024Dec 31, 2024172.4×+135.9
2023Nov 30, 202336.5×+29.8
2022Dec 30, 20226.7×−7.3
2021Dec 31, 202114.0×−6.9
2020Dec 31, 202020.9×−24.9
2019Dec 31, 201945.8×+0.8
2018Dec 31, 201845.0×−69.3
2017Dec 29, 2017114.3×+105.6
2016Dec 30, 20168.7×+1.1
2015Dec 31, 20157.6×−89.9
2014Nov 28, 201497.5×–

More Champions Oncology figures

See a number that looks wrong?